Dr. Reddys Laboratories Ltd.
BSE: 500124 | NSE: DRREDDY
Mid Cap | Pharmaceuticals & Drugs
1350.20
11.70
(0.87%)
< Home
< Back
Dr. Reddys Laboratories Ltd. News
>>
Dr. Reddy's inches up on launching generic version of Vimovo tablets in US market
>>
Dr. Reddy's launches generic version of Vimovo tablets in US market
>>
USFDA completes audit at Dr. Reddy's Lab’s IPDO
>>
Dr. Reddys Laboratories informs about disclosure
>>
Dr. Reddys Laboratories informs about loss of share certificate
>>
Dr. Reddys Laboratories informs about company updates
>>
USFDA seeks voluntary action at Dr. Reddy's Andhra Pradesh facility
>>
Dr. Reddys inches up as USFDA completes audit at Formulations Srikakulum Plant Unit I
>>
USFDA completes audit at Dr. Reddy's Lab’s Formulations Srikakulam Plant
>>
Dr. Reddy’s surges on inking pact to acquire select business divisions of Wockhardt
<<
<
60
61
62
...145
>
>>